Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE).

Miao E, Wo E, Boe L, Lee J, Walch H, Yu H, Parker M, Imber B, Chiang J, Hui C, Myall N, Pollom E, Ni L, Braunstein S, Hadley C, Matsui J, Palmer J, Khandekar M, Marciscano A, Shih H, Lee A, Chen LN, Shu CA, Wang T, Boor I, Patil T, Camidge DR, Messing I, Lebow E, Akdemir E, Kotecha R, Carey K, Shi W, Khoja L, Sahgal A, Soliman H, Rusthoven CG, George Pike LR